BEN
55
2
HPE
75
7
HIG
68
5
SCHW
64
6
ETR
47
-2
COP
47
3
SIG
46
2
A
43
-5
FFIV
47
-3
SWKS
55
2
NI
65
-2
IP
28
-3
OXY
40
2
PNW
53
-3
BA
47
4
GILD
56
6
CCI
36
2
STZ
42
-2
AEP
61
-3
OI
47
-11
BEN
55
2
HPE
75
7
HIG
68
5
SCHW
64
6
ETR
47
-2
COP
47
3
SIG
46
2
A
43
-5
FFIV
47
-3
SWKS
55
2
NI
65
-2
IP
28
-3
OXY
40
2
PNW
53
-3
BA
47
4
GILD
56
6
CCI
36
2
STZ
42
-2
AEP
61
-3
OI
47
-11
Financhill
Back

Avantis US Mid Cap Equity ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
66

AVMC
Avantis US Mid Cap Equity ETF

Last Price:
$71.25
Seasonality Move:
0.35%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
66
Avantis US Mid Cap Equity ETF (AVMC) is a Buy

Is Avantis US Mid Cap Equity ETF a Buy, Sell or Hold?

  • The current Avantis US Mid Cap Equity ETF [AVMC] share price is $71.30. The Score for AVMC is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AVMC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AVMC Stock Price Chart

What is Avantis US Mid Cap Equity ETF's stock price today?

  • The Avantis US Mid Cap Equity ETF share price today is $71.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

AVMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.54 Buy
Relative Strength Index (14 RSI): 57.35 Buy
Chaikin Money Flow: 11370 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.5 - 71.52) Buy
Bollinger Bands (100): (67.98 - 70.42) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

AVMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.38 Sell
20-day SMA: 70.6 Buy
50-day SMA: 69.56 Buy
200-day SMA: 66.31 Buy
8-day EMA: 71.09 Buy
20-day EMA: 70.62 Buy
50-day EMA: 69.87 Buy
200-day EMA: 67.45 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

Avantis US Mid Cap Equity ETF Earnings Growth & AVMC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

Avantis US Mid Cap Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):